US Stock MarketDetailed Quotes

OCUL Ocular Therapeutix

Watchlist

6.170
-0.100-1.59%

Close May 17 16:00 ET

6.080
-0.090-1.46%

Post 16:18 ET

955.66MMarket Cap-5508P/E (TTM)

Ocular Therapeutix Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-69.66%-33.89M

-17.84%-70.23M

-32.41%-22.45M

41.29%-7.73M

-84.58%-20.08M

-7.38%-19.97M

9.07%-59.6M

-11.91%-16.96M

-1.44%-13.17M

45.77%-10.88M

Net income from continuing operations

-113.89%-64.85M

-13.65%-80.74M

-88.01%-29.22M

97.87%-516K

-10.21%-20.68M

-141.73%-30.32M

-984.05%-71.04M

-303.69%-15.54M

-1,010.35%-24.19M

-121.27%-18.77M

Operating gains losses

404.45%33.1M

34.96%-9M

223.59%6.48M

-1,947.35%-20.91M

59.21%-1.13M

194.34%6.56M

82.28%-13.84M

66.97%-5.24M

104.75%1.13M

79.30%-2.77M

Depreciation and amortization

90.48%920K

41.44%2.98M

95.11%958K

74.85%890K

18.12%652K

-13.29%483K

-12.89%2.11M

-13.86%491K

-14.31%509K

-9.66%552K

Other non cash items

60.26%1.97M

25.82%6.11M

25.55%1.55M

69.14%2.07M

3.98%1.25M

3.54%1.23M

4.86%4.85M

4.12%1.24M

5.79%1.23M

4.78%1.21M

Change In working capital

-420.28%-13.01M

-649.37%-7.41M

-206.93%-6.55M

59.01%6.22M

-199.03%-4.58M

50.53%-2.5M

146.50%1.35M

-107.28%-2.14M

45.52%3.91M

209.29%4.63M

-Change in receivables

-282.59%-367K

-2,454.74%-4.85M

-70.06%-2.59M

447.06%3.72M

-326.97%-6.19M

109.70%201K

97.86%-190K

3.79%-1.52M

183.13%680K

153.40%2.73M

-Change in inventory

7.88%-269K

54.28%-331K

88.81%-48K

-17.78%-53K

143.66%62K

-170.37%-292K

-1,377.55%-724K

-1,432.14%-429K

59.09%-45K

-1,390.91%-142K

-Change in prepaid assets

117.83%128K

-620.89%-3.77M

-312.96%-2.93M

-155.69%-269K

-82.39%153K

-986.42%-718K

815.84%723K

18.76%-710K

-48.62%483K

206.36%869K

-Change in payables and accrued expense

-669.68%-12.34M

32.55%1.36M

-172.39%-590K

-4.02%2.84M

-49.86%705K

61.48%-1.6M

-81.44%1.02M

47.11%815K

6.74%2.96M

-20.61%1.41M

-Change in other current assets

-0.96%413K

149.45%1.57M

----

497.14%417K

-424.97%-3.18M

----

-Change in other current liabilities

-49.28%-515K

-166.43%-1.81M

----

---345K

300.96%2.73M

----

-Change in other working capital

63.13%-59K

-55.66%427K

-194.94%-150K

88.10%-20K

323.96%757K

-112.20%-160K

-3.70%963K

--158K

---168K

---338K

Cash from discontinued investing activities

Operating cash flow

-69.66%-33.89M

-17.84%-70.23M

-32.41%-22.45M

41.29%-7.73M

-84.58%-20.08M

-7.38%-19.97M

9.07%-59.6M

-11.91%-16.96M

-1.44%-13.17M

45.77%-10.88M

Investing cash flow

Cash flow from continuing investing activities

92.45%-255K

-63.85%-6.09M

78.65%-459K

67.38%-259K

-302.02%-1.99M

-1,124.28%-3.38M

-211.14%-3.72M

-240.73%-2.15M

-187.68%-794K

-283.72%-495K

Net PPE purchase and sale

92.45%-255K

-63.85%-6.09M

78.65%-459K

67.38%-259K

-302.02%-1.99M

-1,124.28%-3.38M

-211.14%-3.72M

-240.73%-2.15M

-187.68%-794K

-283.72%-495K

Cash from discontinued investing activities

Investing cash flow

92.45%-255K

-63.85%-6.09M

78.65%-459K

67.38%-259K

-302.02%-1.99M

-1,124.28%-3.38M

-211.14%-3.72M

-240.73%-2.15M

-187.68%-794K

-283.72%-495K

Financing cash flow

Cash flow from continuing financing activities

411,724.36%321.22M

11,580.06%169.83M

23,517.90%108.17M

13,786.36%51.94M

1,856.39%9.65M

-39.53%78K

-49.00%1.45M

-31.33%458K

-44.92%374K

-81.51%493K

Net issuance payments of debt

--0

--56.35M

--0

--56.35M

--0

Net common stock issuance

--316.35M

--117.26M

--107.73M

--708K

--8.82M

--0

----

Proceeds from stock option exercised by employees

6,143.59%4.87M

-3.58%1.4M

-3.71%441K

-83.42%62K

66.53%821K

-39.53%78K

-59.28%1.45M

-31.33%458K

-44.92%374K

-52.04%493K

Net other financing activities

----

---5.18M

--0

----

Cash from discontinued financing activities

Financing cash flow

411,724.36%321.22M

11,580.06%169.83M

23,517.90%108.17M

13,786.36%51.94M

1,856.39%9.65M

-39.53%78K

-49.00%1.45M

-31.33%458K

-44.92%374K

-81.51%493K

Net cash flow

Beginning cash position

89.86%197.57M

-37.28%104.06M

-8.47%112.31M

-49.84%68.37M

-45.11%80.79M

-37.28%104.06M

-27.80%165.93M

-32.22%122.71M

-29.60%136.3M

-30.29%147.18M

Current changes in cash

1,333.48%287.08M

251.15%93.51M

557.14%85.26M

423.38%43.94M

-14.18%-12.42M

-24.15%-23.27M

3.18%-61.86M

-23.37%-18.65M

-8.03%-13.59M

37.90%-10.88M

End cash Position

499.89%484.65M

89.86%197.57M

-8.47%112.31M

-49.84%68.37M

-45.11%80.79M

-37.28%104.06M

-32.22%122.71M

-29.60%136.3M

Free cash flow

-46.21%-34.14M

-20.54%-76.32M

-19.91%-22.91M

42.77%-7.99M

-94.05%-22.07M

-23.71%-23.35M

5.13%-63.32M

-21.06%-19.11M

-5.32%-13.96M

43.67%-11.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-69.66%-33.89M	-17.84%-70.23M	-32.41%-22.45M	41.29%-7.73M	-84.58%-20.08M	-7.38%-19.97M	9.07%-59.6M	-11.91%-16.96M	-1.44%-13.17M	45.77%-10.88M
Net income from continuing operations	-113.89%-64.85M	-13.65%-80.74M	-88.01%-29.22M	97.87%-516K	-10.21%-20.68M	-141.73%-30.32M	-984.05%-71.04M	-303.69%-15.54M	-1,010.35%-24.19M	-121.27%-18.77M
Operating gains losses	404.45%33.1M	34.96%-9M	223.59%6.48M	-1,947.35%-20.91M	59.21%-1.13M	194.34%6.56M	82.28%-13.84M	66.97%-5.24M	104.75%1.13M	79.30%-2.77M
Depreciation and amortization	90.48%920K	41.44%2.98M	95.11%958K	74.85%890K	18.12%652K	-13.29%483K	-12.89%2.11M	-13.86%491K	-14.31%509K	-9.66%552K
Other non cash items	60.26%1.97M	25.82%6.11M	25.55%1.55M	69.14%2.07M	3.98%1.25M	3.54%1.23M	4.86%4.85M	4.12%1.24M	5.79%1.23M	4.78%1.21M
Change In working capital	-420.28%-13.01M	-649.37%-7.41M	-206.93%-6.55M	59.01%6.22M	-199.03%-4.58M	50.53%-2.5M	146.50%1.35M	-107.28%-2.14M	45.52%3.91M	209.29%4.63M
-Change in receivables	-282.59%-367K	-2,454.74%-4.85M	-70.06%-2.59M	447.06%3.72M	-326.97%-6.19M	109.70%201K	97.86%-190K	3.79%-1.52M	183.13%680K	153.40%2.73M
-Change in inventory	7.88%-269K	54.28%-331K	88.81%-48K	-17.78%-53K	143.66%62K	-170.37%-292K	-1,377.55%-724K	-1,432.14%-429K	59.09%-45K	-1,390.91%-142K
-Change in prepaid assets	117.83%128K	-620.89%-3.77M	-312.96%-2.93M	-155.69%-269K	-82.39%153K	-986.42%-718K	815.84%723K	18.76%-710K	-48.62%483K	206.36%869K
-Change in payables and accrued expense	-669.68%-12.34M	32.55%1.36M	-172.39%-590K	-4.02%2.84M	-49.86%705K	61.48%-1.6M	-81.44%1.02M	47.11%815K	6.74%2.96M	-20.61%1.41M
-Change in other current assets	-0.96%413K	149.45%1.57M	----	----	----	497.14%417K	-424.97%-3.18M	----	----	----
-Change in other current liabilities	-49.28%-515K	-166.43%-1.81M	----	----	----	---345K	300.96%2.73M	----	----	----
-Change in other working capital	63.13%-59K	-55.66%427K	-194.94%-150K	88.10%-20K	323.96%757K	-112.20%-160K	-3.70%963K	--158K	---168K	---338K
Cash from discontinued investing activities
Operating cash flow	-69.66%-33.89M	-17.84%-70.23M	-32.41%-22.45M	41.29%-7.73M	-84.58%-20.08M	-7.38%-19.97M	9.07%-59.6M	-11.91%-16.96M	-1.44%-13.17M	45.77%-10.88M
Investing cash flow
Cash flow from continuing investing activities	92.45%-255K	-63.85%-6.09M	78.65%-459K	67.38%-259K	-302.02%-1.99M	-1,124.28%-3.38M	-211.14%-3.72M	-240.73%-2.15M	-187.68%-794K	-283.72%-495K
Net PPE purchase and sale	92.45%-255K	-63.85%-6.09M	78.65%-459K	67.38%-259K	-302.02%-1.99M	-1,124.28%-3.38M	-211.14%-3.72M	-240.73%-2.15M	-187.68%-794K	-283.72%-495K
Cash from discontinued investing activities
Investing cash flow	92.45%-255K	-63.85%-6.09M	78.65%-459K	67.38%-259K	-302.02%-1.99M	-1,124.28%-3.38M	-211.14%-3.72M	-240.73%-2.15M	-187.68%-794K	-283.72%-495K
Financing cash flow
Cash flow from continuing financing activities	411,724.36%321.22M	11,580.06%169.83M	23,517.90%108.17M	13,786.36%51.94M	1,856.39%9.65M	-39.53%78K	-49.00%1.45M	-31.33%458K	-44.92%374K	-81.51%493K
Net issuance payments of debt	--0	--56.35M	--0	--56.35M	--0	--0	--0	--0	--0	--0
Net common stock issuance	--316.35M	--117.26M	--107.73M	--708K	--8.82M	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	6,143.59%4.87M	-3.58%1.4M	-3.71%441K	-83.42%62K	66.53%821K	-39.53%78K	-59.28%1.45M	-31.33%458K	-44.92%374K	-52.04%493K
Net other financing activities	----	---5.18M	--0	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	411,724.36%321.22M	11,580.06%169.83M	23,517.90%108.17M	13,786.36%51.94M	1,856.39%9.65M	-39.53%78K	-49.00%1.45M	-31.33%458K	-44.92%374K	-81.51%493K
Net cash flow
Beginning cash position	89.86%197.57M	-37.28%104.06M	-8.47%112.31M	-49.84%68.37M	-45.11%80.79M	-37.28%104.06M	-27.80%165.93M	-32.22%122.71M	-29.60%136.3M	-30.29%147.18M
Current changes in cash	1,333.48%287.08M	251.15%93.51M	557.14%85.26M	423.38%43.94M	-14.18%-12.42M	-24.15%-23.27M	3.18%-61.86M	-23.37%-18.65M	-8.03%-13.59M	37.90%-10.88M
End cash Position	499.89%484.65M	89.86%197.57M	89.86%197.57M	-8.47%112.31M	-49.84%68.37M	-45.11%80.79M	-37.28%104.06M	-37.28%104.06M	-32.22%122.71M	-29.60%136.3M
Free cash flow	-46.21%-34.14M	-20.54%-76.32M	-19.91%-22.91M	42.77%-7.99M	-94.05%-22.07M	-23.71%-23.35M	5.13%-63.32M	-21.06%-19.11M	-5.32%-13.96M	43.67%-11.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall